Searched for
PFIZER DRUG SUPPLY
US nod in Hand, Pfizer is looking for partners to make Covid drug in IndiaThe company has begun investing $1 billion, at risk, in the manufacture of its potential Covid-19 oral antiviral drug with the goal of maki...
Good news on Covid therapy frontExperience with the Omicron variant so far makes clear that while vaccines are critical for reducing the virulence of the disease, therapie...
Pfizer confirms COVID pill's results, potency versus omicronThe Food and Drug Administration is expected to soon rule on whether to authorize Pfizer's pill and a competing pill from Merck, which was ...
Local firms gear up to seek licence for Pfizer's Covid drugUS drug giant Pfizer on Tuesday announced a deal with MPP - a UN-backed public health organization - to issue royalty-free voluntary licenc...
Pfizer to allow generic versions of its COVID-19 pill in 95 countriesThe voluntary licensing agreement between Pfizer and the MPP will allow the United Nations-backed group to grant sub-licenses to qualified ...
US FDA nod may help speed up Pfizer vaccine rollout in India“India will have to give approval if it has to secure free doses of Pfizer vaccine from the Covax facility,” an official said. “Without giv...
Pfizer rises nearly 2% after it seeks nod for vaccine authorization in IndiaA committee of experts is likely to meet this week to consider Pfizer Inc’s application seeking emergency use authorisation for its Covid v...
Trials and Hopes: Way ahead for Covid-19 treatmentThe leaders of big pharma came together for a joint press conference to give an update on the way ahead for Covid-19 treatment and vaccines...
Will Trump tweet on Pfizer cut short the pharma rally?On July 1, Pfizer increased the prices of over 40 drugs including Viagra.
Drug firm Pfizer to close its Navi Mumbai plantPfizer said that decision to close the plant is based on an assessment of its long term viability and its ability to achieve the needed pro...
- Watson Pharma launches Lipitor generic
Watson’s launch raises questions on India’s third-largest drug company Ranbaxy Laboratories’ revenues from the drug.
- Lipitor goes off patent today, Pfizer vs Ranbaxy-led Indian pharma's war for blockbuster drugs intensifies
But for Indian companies, it was not always supposed to be like this. The end of Lipitor’s patent was meant to be a eureka moment for Ranba...
- Strides Arcolabs looks to seal more drug supply deals with global pharma cos
Strides Acrolabs is discussing drug supply deal for niche therapeutics areas with global drug pharma companies.
- Cipla in talks to supply drugs to Germany’s BI
Boehringer Ingelheim in talks with Cipla for supply of generic drugs to the $17-bn German coa for two drugs.
- Cipla in talks with global cos for research agreement
Mumbai-based drugmaker Cipla is in talks with global pharma majors for a drug research and supply agreement, said a top company executive o...
- Pfizer scans India for shopping options
Pfizer has approached several Indian drugmakers for possible alliances as part of moves to try and bolster revenues threatened by the expir...
- Pfizer, Nicholas Piramal hit by codeine shortage
Hit by the shortage of raw material codeine, India’s highest selling drug (in value) Pfizer’s cough syrup Corex has slipped to the eighth s...